Cannabis business licensing provisions modification

A bill for an act

relating to cannabis; modifying cannabis business licensing provisions; establishing

a cannabis macrobusiness license; amending Minnesota Statutes 2024, sections

342.01, subdivisions 14, 52, 54; 342.09, subdivision 3; 342.175; 342.22,

subdivisions 1, 5; 342.27, subdivision 12; 342.35, subdivision 1; 342.37, subdivision

1; 342.41, subdivision 1; 342.51, by adding subdivisions; 342.515, as amended;

342.61, subdivision 5; 342.63, subdivision 4; 342.80; Minnesota Statutes 2025

Supplement, sections 342.01, subdivision 48; 342.10; 342.11; 342.12; 342.13;

342.18, subdivision 2; 342.22, subdivision 3; 342.40, subdivision 7; 342.51,

subdivision 2; 342.61, subdivision 4; 342.63, subdivisions 2, 3, 6; repealing

Minnesota Statutes 2024, section 342.51, subdivision 1.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2024, section 342.01, subdivision 14, is amended to read:

Subd. 14.

Cannabis business.

"Cannabis business" means any of the following licensed

under this chapter:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service; and

(11)
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
.

Sec. 2.

Minnesota Statutes 2025 Supplement, section 342.01, subdivision 48, is amended

to read:

Subd. 48.

License holder.

"License holder" means a person, cooperative, or business

that holds any of the following licenses:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service;

(11) lower-potency hemp edible manufacturer;

(12) lower-potency hemp edible wholesaler;

(13) lower-potency hemp edible retailer; or

(14)
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
.

Sec. 3.

Minnesota Statutes 2024, section 342.01, subdivision 52, is amended to read:

Subd. 52.

Medical cannabinoid product.

(a) "Medical cannabinoid product" means a
new text begin

cannabis
new text end
product that
deleted text begin
:
deleted text end

deleted text begin

(1) consists of or contains cannabis concentrate or hemp concentrate or is infused with

cannabinoids, including but not limited to artificially derived cannabinoids; and

deleted text end

deleted text begin

(2)
deleted text end
is provided to a patient enrolled in the registry program;
new text begin
a visiting patient;
new text end
a registered

designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a

registered designated caregiver, cannabis retailer, or cannabis business with a medical

cannabis retail endorsement to treat or alleviate the symptoms of a qualifying medical

condition.

deleted text begin

(b) A medical cannabinoid product must be in the form of:

deleted text end

deleted text begin

(1) liquid, including but not limited to oil;

deleted text end

deleted text begin

(2) pill;

deleted text end

deleted text begin

(3) liquid or oil for use with a vaporized delivery method;

deleted text end

deleted text begin

(4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;

deleted text end

deleted text begin

(5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and

sublingual tablets;

deleted text end

deleted text begin

(6) edible products in the form of gummies and chews;

deleted text end

deleted text begin

(7) topical formulation; or

deleted text end

deleted text begin

(8) any allowable form or delivery method approved by the office.

deleted text end

deleted text begin

(c) Medical cannabinoid product does not include adult-use cannabis products or

hemp-derived consumer products.

deleted text end

new text begin

(b) A medical cannabinoid product may contain hemp concentrate or may be infused

with cannabinoids derived from hemp. A medical cannabinoid product is not subject to

potency limits established by the office in rule.

new text end

Sec. 4.

Minnesota Statutes 2024, section 342.01, subdivision 54, is amended to read:

Subd. 54.

Medical cannabis flower.

"Medical cannabis flower" means cannabis flower

provided to a patient enrolled in the registry program or a visiting patient; a registered

designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a

registered designated caregiver, cannabis retailer, or cannabis business with a medical

cannabis retail endorsement to treat or alleviate the symptoms of a qualifying medical

condition.
deleted text begin
Medical cannabis flower does not include adult-use cannabis flower.
deleted text end

Sec. 5.

Minnesota Statutes 2024, section 342.09, subdivision 3, is amended to read:

Subd. 3.

Home extraction of cannabis concentrate by use of volatile solvent

prohibited.

No person may use a volatile solvent to separate or extract cannabis concentrate

or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness,
new text begin
cannabis

macrobusiness,
new text end
cannabis manufacturer,
deleted text begin
medical cannabis combination business,
deleted text end
or

lower-potency hemp edible manufacturer license issued under this chapter.

Sec. 6.

Minnesota Statutes 2025 Supplement, section 342.10, is amended to read:

342.10 LICENSES; TYPES.

The office shall issue the following types of license:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service;

(11) lower-potency hemp edible manufacturer;

(12) lower-potency hemp edible wholesaler;

(13) lower-potency hemp edible retailer; and

(14)
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
.

Sec. 7.

Minnesota Statutes 2025 Supplement, section 342.11, is amended to read:

342.11 LICENSES; FEES.

(a) The office shall require the payment of application fees, initial licensing fees, and

renewal licensing fees as provided in this section. The initial license fee shall include the

fee for initial issuance of the license and the first annual renewal. The renewal fee shall be

charged at the time of the second renewal and each subsequent annual renewal thereafter.

Nothing in this section prohibits a local unit of government from charging the retailer

registration fee established in section
342.22
. Application fees, initial licensing fees, and

renewal licensing fees are nonrefundable.

(b) Application and licensing fees shall be as follows:

(1) for a cannabis microbusiness:

(i) an application fee of $500;

(ii) an initial license fee of $0; and

(iii) a renewal license fee of $2,000;

(2) for a cannabis mezzobusiness:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(3) for a cannabis cultivator:

(i) an application fee of $10,000;

(ii) an initial license fee of $20,000; and

(iii) a renewal license fee of $30,000;

(4) for a cannabis manufacturer:

(i) an application fee of $10,000;

(ii) an initial license fee of $10,000; and

(iii) a renewal license fee of $20,000;

(5) for a cannabis retailer:

(i) an application fee of $2,500;

(ii) an initial license fee of $2,500; and

(iii) a renewal license fee of $5,000;

(6) for a cannabis wholesaler:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(7) for a cannabis transporter:

(i) an application fee of $250;

(ii) an initial license fee of $500; and

(iii) a renewal license fee of $1,000;

(8) for a cannabis testing facility:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(9) for a cannabis delivery service:

(i) an application fee of $250;

(ii) an initial license fee of $500; and

(iii) a renewal license fee of $1,000;

(10) for a cannabis event organizer:

(i) an application fee of $750; and

(ii) an initial license fee of $750;

(11) for a lower-potency hemp edible manufacturer:

(i) an application fee of $250;

(ii) an initial license fee of $1,000; and

(iii) a renewal license fee of $1,000;

(12) for a lower-potency hemp edible wholesaler:

(i) an application fee of $250;

(ii) an initial license fee of $10,000; and

(iii) a renewal license fee of $10,000;

(13) for a lower-potency hemp edible retailer:

(i) an application fee of $250 or, if the lower-potency hemp retailer operates more than

one retail location, $250 per retail location;

(ii) an initial license fee of $250 or, if the lower-potency hemp retailer operates more

than one retail location, $250 per retail location; and

(iii) a renewal license fee of $250 or, if the lower-potency hemp retailer operates more

than one retail location, $250 per retail location; and

(14) for a
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
:

(i) an application fee of $10,000;

(ii) an initial license fee of $20,000; and

(iii) a renewal license fee of $70,000.

Sec. 8.

Minnesota Statutes 2025 Supplement, section 342.12, is amended to read:

342.12 LICENSES; TRANSFERS; ADJUSTMENTS.

(a) Licenses issued under this chapter that are available to all applicants pursuant to

section
342.14, subdivision 1b
, paragraph (c), may be freely transferred subject to the prior

written approval of the office unless the license holder has not received a final site inspection

or the license holder is a social equity applicant.

(b) Licenses issued as social equity licenses pursuant to either section
342.14, subdivision

1b, paragraph (b), or section
342.175
, paragraph (b), may only be transferred to another

social equity applicant for three years after the date on which the office issues the license.

Three years after the date of issuance, a license holder may transfer a license to any entity.

Transfer of a license that was issued as a social equity license must be reviewed by the

Division of Social Equity and is subject to the prior written approval of the office.

(c) Preliminary license approval issued pursuant to section
342.14, subdivision 5
, may

not be transferred.

(d) A new license must be obtained when:

(1) the form of the
deleted text begin
licensee's
deleted text end

new text begin
license holder's
new text end
legal business structure converts or changes

to a different type of legal business structure; or

(2) the
deleted text begin
licensee
deleted text end

new text begin
license holder
new text end
dissolves; consolidates; reorganizes; undergoes bankruptcy,

insolvency, or receivership proceedings; merges with another legal organization; or assigns

all or substantially all of its assets for the benefit of creditors.

(e) Licenses must be renewed annually.

(f)
deleted text begin
License holders may petition the office to adjust the tier of a license issued within a

license category if the license holder meets all applicable requirements
deleted text end
new text begin
Beginning January

1, 2027, the office may determine whether licenses are available for a license holder that is

a cannabis microbusiness or cannabis mezzobusiness to reclassify the license holder as

another type of business, either as a cannabis mezzobusiness or cannabis macrobusiness.

Applicants for cannabis macrobusiness licenses are subject to the requirements of section

342.18. If the office determines that licenses are available subject to section 342.14,

subdivision 1a, the office must announce the number of available cannabis mezzobusiness

licenses and cannabis macrobusiness licenses and the date on which the office will begin

accepting petitions from applicants seeking reclassification. When approving reclassification

of a license, the office must give priority to: (1) any cannabis microbusiness with a medical

retail endorsement that is seeking reclassification; or (2) any cannabis mezzobusiness with

a medical endorsement that is seeking reclassification. The number of reclassified licenses

available to social equity applicants must be equal to or greater than the number of

reclassified licenses available to all applicants. A license holder that seeks to reclassify its

license as a cannabis mezzobusiness or cannabis macrobusiness must include in its application

a transition plan that describes how the license holder will comply with all statutes and rules

applicable to the reclassified license. Reclassification according to this paragraph must not

remove the social equity license status from a social equity license
new text end
.

(g) The office by rule may permit the relocation of a licensed cannabis business; permit

the relocation of an approved operational location, including a cultivation, manufacturing,

processing, or retail location; adopt requirements for the submission of a license relocation

application; establish standards for the approval of a relocation application; and charge a

fee not to exceed $250 for reviewing and processing applications. Relocation of a licensed

premises pursuant to this paragraph does not extend or otherwise modify the license term

of the license subject to relocation.

Sec. 9.

Minnesota Statutes 2025 Supplement, section 342.13, is amended to read:

342.13 LOCAL CONTROL.

(a) A local unit of government may not prohibit the possession, transportation, or use

of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived

consumer products authorized under this chapter.

(b) Except as provided in section
342.22
, a local unit of government may not prohibit

the establishment or operation of a cannabis business or hemp business licensed under this

chapter.

(c) A local unit of government may adopt reasonable restrictions on the time, place, and

manner of the operation of a cannabis business provided that such restrictions do not prohibit

the establishment or operation of cannabis businesses. A local unit of government may

prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a

day care, residential treatment facility, or an attraction within a public park that is regularly

used by minors, including a playground or athletic field.

(d) The office shall work with local units of government to:

(1) develop model ordinances for reasonable restrictions on the time, place, and manner

of the operation of a cannabis business;

(2) develop standardized forms and procedures for the issuance of a retail registration

pursuant to section
342.22
; and

(3) develop model policies and procedures for the performance of compliance checks

required under section
342.22
.

(e) If a local unit of government is conducting studies or has authorized a study to be

conducted or has held or has scheduled a hearing for the purpose of considering adoption

or amendment of reasonable restrictions on the time, place, and manner of the operation of

a cannabis business, the governing body of the local unit of government may adopt an

interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting

the planning process and the health, safety, and welfare of its citizens. Before adopting the

interim ordinance, the governing body must hold a public hearing. The interim ordinance

may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction

or a portion thereof until January 1, 2025.

(f) Within 30 days of receiving a copy of an application from the office, a local unit of

government shall certify on a form provided by the office whether a proposed cannabis

business complies with local zoning ordinances and, if applicable, whether the proposed

business complies with the state fire code and building code. The office may not issue a

license if the local unit of government informs the office that the cannabis business does

not meet local zoning and land use laws. If the local unit of government does not provide

the certification to the office within 30 days of receiving a copy of an application from the

office, the office may issue a license.

(g) The office by rule shall establish an expedited complaint process to receive, review,

and respond to complaints made by a local unit of government about a cannabis business.

At a minimum, the expedited complaint process shall require the office to provide an initial

response to the complaint within seven days and perform any necessary inspections within

30 days. Nothing in this paragraph prohibits a local unit of government from enforcing a

local ordinance. If a local unit of government notifies the office that a cannabis business

other than a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness
new text begin
, cannabis

macrobusiness,
new text end
or lower-potency hemp edible retailer with a retail operations endorsement
deleted text begin
,

or medical cannabis combination business operating a retail location
deleted text end
poses an immediate

threat to the health or safety of the public, the office must respond within one business day

and may take any action described in section
342.19
or
342.21
.

(h) A local government unit that issues a cannabis retailer registration under section

342.22
may, by ordinance, limit the number of licensed cannabis retailers, cannabis

mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with

a retail operations endorsement to no fewer than one registration for every 12,500 residents.

(i) If a county has one active registration for every 12,500 residents, a city or town within

the county is not obligated to register a cannabis business.

(j) Nothing in this section shall prohibit a local government unit from allowing licensed

cannabis retailers in excess of the minimums set in paragraph (h).

(k) Notwithstanding the foregoing provisions, the state shall not issue a license to any

cannabis business to operate in Indian country, as defined in United States Code, title 18,

section 1151, of a Minnesota Tribal government without the consent of the Tribal

government.

Sec. 10.

Minnesota Statutes 2024, section 342.175, is amended to read:

342.175 SOCIAL EQUITY LICENSE CLASSIFICATION.

(a) The office must classify licenses listed in section
342.10
, clauses (1) to (10) and
deleted text begin
(13)
deleted text end
new text begin

(14)
new text end
as:

(1) available to social equity applicants who meet the requirements of section
342.17
;

and

(2) available to all applicants.

(b) The office must classify any license issued to a social equity applicant as a social

equity license.

Sec. 11.

Minnesota Statutes 2025 Supplement, section 342.18, subdivision 2, is amended

to read:

Subd. 2.

Vertical integration prohibited; exceptions.

(a) Except as otherwise provided

in this subdivision, the office shall not issue licenses to a single applicant that would result

in the applicant being vertically integrated in violation of the provisions of this chapter.

(b) Nothing in this section prohibits or limits the issuance of microbusiness licenses,

mezzobusiness licenses, or
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
licenses,

or the issuance of lower-potency hemp edible manufacturer, lower-potency hemp edible

wholesaler, and lower-potency hemp edible retailer licenses to the same person or entity.

Sec. 12.

Minnesota Statutes 2024, section 342.22, subdivision 1, is amended to read:

Subdivision 1.

Registration required.

Before making retail sales to customers or patients,

a cannabis microbusiness, cannabis mezzobusiness, cannabis retailer,
deleted text begin
medical
deleted text end
cannabis
deleted text begin

combination business
deleted text end
new text begin
macrobusiness
new text end
, or lower-potency hemp edible retailer must register

with the city, town, or county in which the retail establishment is located. A county may

issue a registration in cases where a city or town has provided consent for the county to

issue the registration for the jurisdiction.

Sec. 13.

Minnesota Statutes 2025 Supplement, section 342.22, subdivision 3, is amended

to read:

Subd. 3.

Issuance of registration.

(a) A local unit of government shall issue a retail

registration to a cannabis microbusiness with a retail operations endorsement, cannabis

mezzobusiness with a retail operations endorsement, cannabis retailer,
deleted text begin
medical
deleted text end
cannabis
deleted text begin

combination business
deleted text end
new text begin
macrobusiness
new text end
operating a retail location, or lower-potency hemp

edible retailer that:

(1) has a valid license or preliminary license approval issued by the office;

(2) has paid the registration fee or renewal fee pursuant to subdivision 2;

(3) is found to be in compliance with the requirements of this chapter at any preliminary

compliance check that the local unit of government performs; and

(4) if applicable, is current on all property taxes and assessments at the location where

the retail establishment is located.

(b) Before issuing a retail registration, the local unit of government may conduct a

preliminary compliance check to ensure that the cannabis business or hemp business is in

compliance with any applicable local ordinance established pursuant to section
342.13
.

(c) A local unit of government shall renew the retail registration of a cannabis business

or hemp business when the office renews the license of the cannabis business or hemp

business.

(d) A retail registration issued under this section may not be transferred.

Sec. 14.

Minnesota Statutes 2024, section 342.22, subdivision 5, is amended to read:

Subd. 5.

Registration suspension and cancellation; notice to office; penalties.

(a) If

a local unit of government determines that a cannabis business or hemp business with a

retail registration issued by the local unit of government is not operating in compliance with

the requirements of a local ordinance authorized under section
342.13
or that the operation

of the business poses an immediate threat to the health or safety of the public, the local unit

of government may suspend the retail registration of the cannabis business or hemp business.

The local unit of government must immediately notify the office of the suspension and shall

include a description of the grounds for the suspension.

(b) The office shall review the retail registration suspension and may order reinstatement

of the retail registration or take any action described in section
342.19
or
342.21
.

(c) The retail registration suspension must be for up to 30 days unless the office suspends

the license and operating privilege of the cannabis business or hemp business for a longer

period or revokes the license.

(d) The local unit of government may reinstate the retail registration if the local unit of

government determines that any violation has been cured. The local unit of government

must reinstate the retail registration if the office orders reinstatement.

(e) No cannabis microbusiness, cannabis mezzobusiness, cannabis retailer,
deleted text begin
medical
deleted text end

cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
, or lower-potency hemp edible retailer may

make any sale to a customer or patient without a valid retail registration with a local unit

of government and a valid license with any applicable endorsement from the office. A local

unit of government may impose a civil penalty of up to $2,000 for each violation of this

paragraph.

Sec. 15.

Minnesota Statutes 2024, section 342.27, subdivision 12, is amended to read:

Subd. 12.

Prohibitions.

A cannabis business with a license or endorsement authorizing

the retail sale of cannabis flower or cannabis products shall not:

(1) sell cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived

consumer products to a person who is visibly intoxicated;

(2) knowingly sell more cannabis flower, cannabis products, lower-potency hemp edibles,

or hemp-derived consumer products than a customer is legally permitted to possess;

(3) give away immature cannabis plants or seedlings, cannabis flower, cannabis products,

lower-potency hemp edibles, or hemp-derived consumer products;

(4) operate a drive-through window;

(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,

lower-potency hemp edibles, or hemp-derived consumer products in vending machines;
deleted text begin
or
deleted text end

(6) sell cannabis plants, cannabis flower, or cannabis products if the cannabis retailer

knows that any required security or statewide monitoring systems are not operational
deleted text begin
.
deleted text end
new text begin
; or
new text end

new text begin

(7) sell medical cannabinoid products to a person who is not registered in the patient

registry or is not enrolled in the registry program as a patient or caregiver.

new text end

Sec. 16.

Minnesota Statutes 2024, section 342.35, subdivision 1, is amended to read:

Subdivision 1.

Authorized actions.

A cannabis transporter license entitles the license

holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis

products, artificially derived cannabinoids, hemp plant parts, hemp concentrate,

lower-potency hemp edibles, and hemp-derived consumer products from cannabis

microbusinesses, cannabis mezzobusinesses,
new text begin
cannabis macrobusinesses,
new text end
cannabis cultivators,

cannabis manufacturers, cannabis wholesalers, lower-potency hemp edible manufacturers,

and industrial hemp growers to cannabis microbusinesses, cannabis mezzobusinesses,
new text begin

cannabis macrobusinesses,
new text end
cannabis manufacturers, cannabis testing facilities, cannabis

wholesalers, cannabis retailers,
new text begin
and
new text end
lower-potency hemp edible retailers
deleted text begin
, and medical

cannabis combination businesses
deleted text end
and perform other actions approved by the office.

Sec. 17.

Minnesota Statutes 2024, section 342.37, subdivision 1, is amended to read:

Subdivision 1.

Authorized actions.

A cannabis testing facility license entitles the license

holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis

products, hemp plant parts, hemp concentrate, artificially derived cannabinoids,

lower-potency hemp edibles, and hemp-derived consumer products from cannabis

microbusinesses, cannabis mezzobusinesses,
new text begin
cannabis macrobusinesses,
new text end
cannabis cultivators,

cannabis manufacturers, cannabis wholesalers, lower-potency hemp edible manufacturers,
deleted text begin

medical cannabis combination businesses,
deleted text end
and industrial hemp growers.

Sec. 18.

Minnesota Statutes 2025 Supplement, section 342.40, subdivision 7, is amended

to read:

Subd. 7.

Cannabis event sales.

(a) Cannabis microbusinesses with a retail endorsement,

cannabis mezzobusinesses with a retail endorsement, cannabis retailers,
deleted text begin
medical
deleted text end
cannabis
deleted text begin

combination businesses
deleted text end
new text begin
macrobusinesses
new text end
operating a retail location, and lower-potency

hemp edible retailers, including the cannabis event organizer, may be authorized to sell

cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency

hemp edibles, and hemp-derived consumer products to customers at a cannabis event.

(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products,

lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must

take place in a retail area as designated in the premises diagram.

(c) Authorized retailers may only conduct sales within their specifically assigned area.

(d) Authorized retailers must verify the age of all customers pursuant to section
342.27
,

subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis

flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer

products to an individual under 21 years of age.

(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use

cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived

consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis

products must be stored in a sample jar or display case and be accompanied by a label or

notice containing the information required to be affixed to the packaging or container

containing adult-use cannabis flower and adult-use cannabis products sold to customers. A

sample may not consist of more than eight grams of adult-use cannabis flower or adult-use

cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams

of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use

cannabis flower or adult-use cannabis product before purchase.

(f) The notice requirements under section
342.27, subdivision 6
, apply to authorized

retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products,

and hemp-derived consumer products for sale at a cannabis event.

(g) Authorized retailers may not:

(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp

edibles, or hemp-derived consumer products to a person who is visibly intoxicated;

(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis

products, lower-potency hemp edibles, or hemp-derived consumer products than a customer

is legally permitted to possess;

(3) sell medical cannabis flower or medical cannabinoid products; or

(4) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,

lower-potency hemp edibles, or hemp-derived consumer products in vending machines.

(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis

product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis

plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles,

and hemp-derived consumer products for sale at a cannabis event must be stored in a secure,

locked container that is not accessible to the public. Such items being stored at a cannabis

event shall not be left unattended.

(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products,

lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis

event must comply with this chapter and rules adopted pursuant to this chapter regarding

the testing, packaging, and labeling of those items.

(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold,

damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring

system.

Sec. 19.

Minnesota Statutes 2024, section 342.41, subdivision 1, is amended to read:

Subdivision 1.

Authorized actions.

A cannabis delivery service license entitles the

license holder to purchase cannabis flower, cannabis products, lower-potency hemp edibles,

and hemp-derived consumer products from licensed cannabis microbusinesses with a retail

endorsement, cannabis mezzobusinesses with a retail endorsement, cannabis retailers, and
deleted text begin

medical
deleted text end
cannabis
deleted text begin
combination businesses
deleted text end
new text begin
macrobusinesses
new text end
; transport and deliver cannabis

flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumable

products to customers; and perform other actions approved by the office.

Sec. 20.

Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to

read:

new text begin

Subd. 1a.

new text end

new text begin

Types of medical cannabis endorsements; authorized actions.

new text end

new text begin

The office

may issue the following types of medical cannabis endorsements to a license holder:

new text end

new text begin

(1) a medical cannabis cultivation endorsement;

new text end

new text begin

(2) a medical cannabis manufacturer endorsement; or

new text end

new text begin

(3) a medical cannabis retail endorsement.

new text end

Sec. 21.

Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to

read:

new text begin

Subd. 1b.

new text end

new text begin

Medical cannabis cultivation endorsement.

new text end

new text begin

(a) A cannabis microbusiness,

cannabis mezzobusiness, cannabis macrobusiness, or cannabis cultivator with a cannabis

cultivation endorsement may apply for and obtain a medical cannabis cultivation

endorsement.

new text end

new text begin

(b) A cannabis business with a medical cannabis cultivation endorsement must:

new text end

new text begin

(1) comply with the requirements of section 342.25; and

new text end

new text begin

(2) otherwise meet all applicable requirements established by the office.

new text end

new text begin

(c) A medical cannabis cultivation endorsement entitles the license holder to perform

the actions authorized in section 342.30, subdivision 1.

new text end

new text begin

(d) A cannabis microbusiness with a medical cannabis cultivation endorsement may

cultivate cannabis in an additional 1,000 square feet indoors or one-quarter acre outdoors

in addition to the limits in section 342.28.

new text end

new text begin

(e) A cannabis mezzobusiness with a medical cannabis cultivation endorsement may

cultivate cannabis in an additional 3,000 square feet indoors or one-half acre outdoors in

addition to the limits in section 342.29.

new text end

new text begin

(f) A cannabis cultivator with a medical cannabis cultivation endorsement may cultivate

an additional 6,000 square feet indoors or one acre outdoors in addition to the limits in

section 342.30.

new text end

new text begin

(g) Annually, at least one quarter of all cannabis flower cultivated by a cannabis business

with a medical cannabis cultivation endorsement must be sold by the license holder to a

cannabis business with a medical cannabis endorsement, including the license holder if the

license holder has a medical cannabis manufacturing endorsement or medical cannabis retail

endorsement.

new text end

Sec. 22.

Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to

read:

new text begin

Subd. 1c.

new text end

new text begin

Medical cannabis manufacturer endorsement.

new text end

new text begin

(a) A cannabis microbusiness,

cannabis mezzobusiness, cannabis macrobusiness, or cannabis manufacturer with a

manufacturing endorsement may apply for and obtain a medical cannabis manufacturer

endorsement.

new text end

new text begin

(b) A cannabis business with a medical cannabis manufacturer endorsement must:

new text end

new text begin

(1) comply with the requirements of section 342.26;

new text end

new text begin

(2) manufacture high medical needs products identified by the office; and

new text end

new text begin

(3) otherwise meet all applicable requirements established by the office.

new text end

new text begin

(c) A medical cannabis manufacturer endorsement entitles a license holder to:

new text end

new text begin

(1) manufacture medical cannabinoid products; and

new text end

new text begin

(2) sell medical cannabinoid products only to other cannabis businesses with a medical

cannabis manufacturer endorsement or medical cannabis retail endorsement.

new text end

new text begin

(d) A medical cannabinoid product must be labeled with a "Minnesota Medical Cannabis"

warning symbol and must only be sold to a person, patient, or caregiver enrolled in the

registry program or a visiting patient.

new text end

new text begin

(e) A medical cannabis manufacturer endorsement held by a cannabis microbusiness

entitles the license holder to increase the use of cannabis by dry weight up to 25 percent

above the limit established by the office in rule.

new text end

new text begin

(f) A medical cannabis manufacturer endorsement held by a cannabis mezzobusiness

entitles the license holder to increase the use of cannabis by dry weight up to 25 percent

above the limit established by the office in rule.

new text end

Sec. 23.

Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to

read:

new text begin

Subd. 1d.

new text end

new text begin

Medical cannabis retail endorsement.

new text end

new text begin

(a) A cannabis microbusiness, cannabis

mezzobusiness, cannabis macrobusiness, or cannabis retailer with a retail operations

endorsement may apply for and obtain a medical cannabis retail endorsement.

new text end

new text begin

(b) A cannabis business with a medical cannabis retail endorsement must:

new text end

new text begin

(1) comply with all requirements of this section and section 342.27;

new text end

new text begin

(2) have at least one member of staff who has earned a medical cannabis consultant

certificate issued by the office and completed the required training or have at least one

member of staff who is a licensed pharmacist under chapter 151;

new text end

new text begin

(3) ensure availability of patient consultations as required under this section;

new text end

new text begin

(4) ensure that patients and caregivers enrolled in the registry program receive priority

service;

new text end

new text begin

(5) carry all products identified by the office as high medical need; and

new text end

new text begin

(6) otherwise meet all applicable requirements established by the office.

new text end

new text begin

(c) The office must identify high medical need products and publish a list of all high

medical need products on the office's publicly accessible website.

new text end

new text begin

(d) A medical cannabis retail endorsement held by a cannabis business entitles the license

holder to perform the actions authorized in section 342.32, subdivision 1.

new text end

new text begin

(e) A cannabis microbusiness with a medical retail endorsement may operate one

additional retail location in excess of the limit in section 342.28, subdivision 2, paragraph

(d), if at least one retail location is located in an area identified by the office as a high medical

need area.

new text end

new text begin

(f) A cannabis mezzobusiness with a medical cannabis retail endorsement may operate

two additional retail locations in excess of the limit in section 342.29, subdivision 2,

paragraph (d), if at least the retail locations are located in an area identified by the office as

a high medical need area.

new text end

new text begin

(g) A cannabis retailer with a medical cannabis retail endorsement may operate up to

three additional retail locations in excess of the limit established in section 342.32,

subdivision 2, if the retail locations are located in an area identified by the office as a high

medical need area.

new text end

Sec. 24.

Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to

read:

new text begin

Subd. 1e.

new text end

new text begin

Additional authorized actions; external transporter endorsement and

medical cannabis delivery endorsement.

new text end

new text begin

(a) A cannabis microbusiness or cannabis

mezzobusiness with at least two medical cannabis endorsements may apply for and obtain

an external transporter endorsement to transport immature cannabis plants and seedlings,

cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant parts,

hemp concentrate, lower-potency hemp edibles, and hemp-derived consumer products to

other cannabis and hemp businesses if the cannabis business:

new text end

new text begin

(1) provides the office with the information required in section 342.35, subdivision 2;

and

new text end

new text begin

(2) complies with the requirements of section 342.36.

new text end

new text begin

(b) A cannabis business with a medical cannabis retail endorsement may apply for and

obtain a medical cannabis delivery endorsement to deliver medical cannabis flower and

medical cannabinoid products to patients enrolled in the registry program; registered

designated caregivers; and parents, legal guardians, and spouses of an enrolled patient if

the cannabis business:

new text end

new text begin

(1) provides the office with the information required in section 342.41, subdivision 2;

and

new text end

new text begin

(2) complies with the requirements of subdivisions 2 and 3 and section 342.42.

new text end

Sec. 25.

Minnesota Statutes 2025 Supplement, section 342.51, subdivision 2, is amended

to read:

Subd. 2.

Distribution requirements.

deleted text begin
(a)
deleted text end
Prior to distribution of medical cannabis flower

or medical cannabinoid products to a person enrolled in the registry program, an employee

of a cannabis business must:

(1) review and confirm the patient's enrollment in the registry program;

(2) verify that the person requesting the distribution of medical cannabis flower or

medical cannabinoid products is the patient
deleted text begin
,
deleted text end
new text begin
;
new text end
the patient's registered designated caregiver
deleted text begin
,
deleted text end
new text begin
;
new text end

or the patient's parent, legal guardian, or spouse using the procedures established by the

office;

(3) confirm that the patient had a consultation with
new text begin
:
new text end
(i) an employee with a valid medical

cannabis consultant certificate issued by the office; or (ii) an employee who is a licensed

pharmacist under chapter 151 to determine the proper medical cannabis flower or medical

cannabinoid product, dosage, and paraphernalia for the patient if required under subdivision

3;

(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid

product that includes recommended dosage requirements and other information as required

by the office; and

(5) provide the patient with any other information required by the office.

deleted text begin

(b) A cannabis business with a medical cannabis retail endorsement may not deliver

medical cannabis flower or medical cannabinoid products to a person enrolled in the registry

program unless the cannabis business with a medical cannabis retail endorsement also holds

a cannabis delivery service license. The delivery of medical cannabis flower and medical

cannabinoid products are subject to the provisions of section
342.42
.

deleted text end

Sec. 26.

Minnesota Statutes 2024, section 342.515, as amended by Laws 2025, chapter

31, sections 89 and 90, is amended to read:

342.515
deleted text begin
MEDICAL
deleted text end
CANNABIS
deleted text begin
COMBINATION BUSINESSES
deleted text end
new text begin

MACROBUSINESSES
new text end
.

Subdivision 1.

Authorized actions.

deleted text begin

(a) A person, cooperative, or business holding a

medical cannabis combination business license is prohibited from owning or operating any

other cannabis business or hemp business or holding an active registration agreement under

section
152.25, subdivision 1
.

deleted text end

deleted text begin

(b) A person or business may hold only one medical cannabis combination business

license.

deleted text end

deleted text begin

(c)
deleted text end
new text begin
(a)
new text end
A
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end

new text begin
macrobusiness
new text end
license
new text begin
, consistent with

the requirements of specific license endorsements approved by the office,
new text end
entitles the license

holder to perform
deleted text begin
any or all of
deleted text end
the following
deleted text begin
within the limits established by this section
deleted text end
new text begin

actions
new text end
:

(1) grow cannabis plants from seed or immature plant to mature plant
deleted text begin
and
deleted text end
new text begin
,
new text end
harvest

adult-use cannabis flower and medical cannabis flower from a mature plant
new text begin
, package and

label cannabis flower for sale to other cannabis businesses, and sell immature cannabis

plants and seedlings and cannabis flower to other cannabis businesses
new text end
;

(2) make cannabis concentrate;

(3) make hemp concentrate, including hemp concentrate with a delta-9

tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(4) manufacture artificially derived cannabinoids;

deleted text begin

(5) manufacture medical cannabinoid products;

deleted text end

deleted text begin

(6)
deleted text end
new text begin
(5)
new text end
manufacture
new text begin
, package, and label
new text end
adult-use cannabis products, lower-potency

hemp edibles, and hemp-derived consumer products for public consumption;

deleted text begin

(7)
deleted text end
new text begin
(6)
new text end
purchase immature cannabis plants and seedlings and cannabis flower from a

cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis

wholesaler, or another
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
;

deleted text begin

(8)
deleted text end
new text begin
(7)
new text end
purchase hemp plant parts and propagules from an industrial hemp grower licensed

under chapter 18K;

deleted text begin

(9)
deleted text end
new text begin
(8)
new text end
purchase cannabis concentrate, hemp concentrate, and artificially derived

cannabinoids from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis

manufacturer, a cannabis wholesaler, or another
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin

macrobusiness
new text end
;

deleted text begin

(10)
deleted text end
new text begin
(9)
new text end
purchase hemp concentrate from an industrial hemp processor licensed under

chapter 18K;

deleted text begin

(11) manufacture, package, and label medical cannabis flower and medical cannabinoid

products for sale to cannabis businesses with a medical cannabis processor endorsement,

cannabis businesses with a medical cannabis retail endorsement, other medical cannabis

combination businesses, and persons in the registry program;

deleted text end

deleted text begin

(12) transport and deliver medical cannabis flower and medical cannabinoid products

to medical cannabis processors, medical cannabis retailers, other medical cannabis

combination businesses, patients enrolled in the registry program, registered designated

caregivers, and parents, legal guardians, and spouses of an enrolled patient;

deleted text end

deleted text begin

(13) manufacture, package, and label adult-use cannabis flower, adult-use cannabis

products, lower-potency hemp edibles, and hemp-derived consumer products for sale to

customers and other cannabis businesses;

deleted text end

deleted text begin

(14) sell medical cannabis flower and medical cannabinoid products to other cannabis

businesses with a medical endorsement, other medical cannabis combination businesses,

and patients enrolled in the registry program, registered designated caregivers, and parents,

legal guardians, and spouses of an enrolled patient;

deleted text end

deleted text begin

(15)
deleted text end
new text begin
(10)
new text end
sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use

cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and

other products authorized by law
deleted text begin
to other cannabis businesses and
deleted text end
to customers;

deleted text begin

(16) transport immature cannabis plants and seedlings, adult-use cannabis flower,

adult-use cannabis products, lower-potency hemp edibles, hemp-derived consumer products,

and other products authorized by law to other cannabis businesses;

deleted text end

deleted text begin

(17)
deleted text end
new text begin
(11)
new text end
sell
deleted text begin
and transport
deleted text end
lower-potency hemp edibles to lower-potency hemp edible

retailers and lower-potency hemp edible wholesalers; and

deleted text begin

(18)
deleted text end
new text begin
(12)
new text end
perform other actions approved by the office.

deleted text begin

(d) A medical cannabis combination business is not required to obtain a medical cannabis

endorsement to perform any actions authorized under this section.

deleted text end

new text begin

(b) A cannabis macrobusiness must apply for and obtain a medical manufacturing

endorsement and at least one other medical cannabis endorsement identified in section

342.51.

new text end

Subd. 2.

Cultivation
new text begin
endorsement
new text end
; size limitations.

new text begin

(a) A cannabis macrobusiness

seeking to cultivate cannabis plants and harvest cannabis flower must obtain a cannabis

cultivation endorsement and comply with section 342.25.

new text end

new text begin

(b) A cannabis macrobusiness that obtains a cannabis cultivation endorsement must

apply for and obtain a medical cannabis cultivation endorsement and comply with section

342.51, subdivision 1b.

new text end

deleted text begin

(a)
deleted text end
new text begin
(c)
new text end
A
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business may cultivate cannabis to be sold as

medical cannabis flower or used in medical cannabinoid products in an area of up to 60,000

square feet of plant canopy subject to the limits on adult-use cannabis cultivation in paragraph

(c). A medical cannabis combination business may cultivate cannabis and manufacture

cannabis in more than one location, except the aggregate total of plant canopy in all locations

must count toward the business' canopy limit.
deleted text end
new text begin
macrobusiness that cultivates cannabis at an

indoor facility may cultivate up to 45,000 square feet of plant canopy.
new text end

deleted text begin

(b)
deleted text end
new text begin
(d)
new text end
A
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end

deleted text begin
may cultivate cannabis to be sold as

adult-use cannabis flower or used in adult-use cannabis products in an area authorized by

the office as described in paragraph (c).
deleted text end
new text begin
macrobusiness that cultivates cannabis at an outdoor

location may cultivate up to four acres of mature, flowering plants.
new text end

deleted text begin

(c) The office shall authorize a medical cannabis combination business to cultivate

cannabis for sale in the adult-use market in an area of plant canopy that is equal to one-half

of the area the business used to cultivate cannabis sold in the medical market in the preceding

year. The office shall establish an annual verification and authorization procedure. The

office may increase the area of plant canopy in which a medical cannabis combination

business is authorized to cultivate cannabis for sale in the adult-use market between

authorization periods if the business demonstrates a significant increase in the sale of medical

cannabis and medical cannabis products.

deleted text end

new text begin

(e) A cannabis macrobusiness with a cannabis cultivation endorsement and a retail

operations endorsement may package and label adult-use cannabis flower, adult-use cannabis

products, lower-potency hemp edibles, and hemp-derived consumer products for sale to

customers.

new text end

new text begin

(f) A cannabis macrobusiness with a medical cannabis cultivation endorsement and a

medical cannabis retail endorsement may package and label medical cannabis flower and

medical cannabinoid products for sale to patients enrolled in the registry program; registered

designated caregivers; and parents, legal guardians, and spouses of an enrolled patient.

new text end

Subd. 3.

deleted text begin
Manufacturing
deleted text end
new text begin
Manufacturer endorsement
new text end
; size limitations.

new text begin
(a) By rule,
new text end

the office may establish limits on cannabis manufacturing that are consistent with the area

of plant canopy a business is authorized to cultivate.
new text begin
Until the office establishes limits by

rule, a cannabis macrobusiness must not use more than 90,000 pounds of cannabis or its

dry-weight equivalent of raw concentrates to manufacture cannabis products.
new text end

new text begin

(b) A cannabis macrobusiness must apply for and obtain a medical cannabis manufacturer

endorsement and must comply with section 342.51, subdivision 1c.

new text end

new text begin

(c) A cannabis macrobusiness may apply for and obtain one or more cannabis

manufacturer endorsements identified in section 342.26.

new text end

Subd. 4.

Retail
new text begin
operations
new text end
new text begin
endorsement;
new text end
locations.

new text begin
(a)
new text end
A
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination

business
deleted text end
new text begin
macrobusiness with a retail operations endorsement
new text end
may operate up to
deleted text begin
one retail

location in each congressional district. A medical cannabis combination business must offer

medical cannabis flower, medical cannabinoid products, or both at every retail location.
deleted text end
new text begin

eight retail locations and, if operating more than five retail locations, must ensure that at

least three retail locations are located in areas identified by the office as high medical need

areas.
new text end

new text begin

(b) A cannabis macrobusiness may apply for and obtain a retail operations endorsement

and must comply with section 342.27.

new text end

new text begin

(c) A cannabis macrobusiness with a retail operations endorsement must apply for and

obtain a medical cannabis retail operations endorsement and comply with section 342.51,

subdivision 1d.

new text end

new text begin

(d) A cannabis macrobusiness with a retail operations endorsement and a medical cannabis

retail operations endorsement must carry and make available for sale, at each retail location,

all high medical need products identified by the office.

new text end

Subd. 5.

Failure to participate; suspension or revocation of license.

The office may

suspend or revoke a
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end

new text begin
macrobusiness
new text end
license if the

office determines that the business is no longer actively participating in the medical cannabis

market.
deleted text begin
The office may, by rule, establish minimum requirements related to cannabis

cultivation, manufacturing of medical cannabinoid products, retail sales of medical cannabis

flower and medical cannabinoid products, and other relevant criteria to demonstrate active

participation in the medical cannabis market.
deleted text end
new text begin
If a cannabis macrobusiness fails to obtain or

operate under a medical cannabis manufacturer endorsement or fails to carry and make

available for sale, at each retail location, high medical need products identified by the office,

the office may suspend or revoke the cannabis macrobusiness's license under this subdivision.

new text end

deleted text begin

Subd. 6.

deleted text end

deleted text begin

Operations.

deleted text end

deleted text begin

A medical cannabis combination business must comply with the

relevant requirements of sections
342.25
,
342.26
,
342.27
, and
342.51, subdivisions 2
to 5.

deleted text end

Subd. 7.

deleted text begin
Transportation
deleted text end
new text begin
Internal transporter endorsement
new text end
.

new text begin
(a)
new text end
A
deleted text begin
medical
deleted text end
cannabis
deleted text begin

combination business
deleted text end
new text begin
macrobusiness
new text end
may
new text begin
obtain an internal transporter endorsement to
new text end

transport immature cannabis plants and seedlings, cannabis flower, cannabis products,

artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp

edibles, and hemp-derived consumer products
new text begin
between facilities owned by the license holder
new text end

if the
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
:

(1) provides the office with the information described in section
342.35, subdivision 2
;

and

(2) complies with the requirements of section
342.36
.

new text begin

(b) A cannabis macrobusiness with at least two medical cannabis endorsements may

apply for and obtain an external transporter endorsement to transport immature cannabis

plants and seedlings, cannabis flower, cannabis products, artificially derived cannabinoids,

hemp plant parts, hemp concentrate, lower-potency hemp edibles, and hemp-derived

consumer products to other cannabis and hemp businesses if the cannabis macrobusiness:

new text end

new text begin

(1) provides the office with the information required under section 342.35, subdivision

2; and

new text end

new text begin

(2) complies with the requirements of section 342.36.

new text end

new text begin

(c) A cannabis macrobusiness with a medical cannabis endorsement is not required to

obtain an external transporter endorsement to transport immature cannabis plants and

seedlings, cannabis flower, cannabis products, lower-potency hemp edibles, hemp-derived

consumer products, medical cannabis flower, and medical cannabinoid products to a cannabis

testing facility.

new text end

new text begin

Subd. 8.

new text end

new text begin

Multiple licenses.

new text end

new text begin

(a) A person, cooperative, or business holding a cannabis

macrobusiness license may also hold a cannabis event organizer license.

new text end

new text begin

(b) Except as provided in paragraph (a), a person, cooperative, or business holding a

cannabis macrobusiness license is prohibited from owning or operating any other cannabis

business or hemp business or holding more than one cannabis macrobusiness license.

new text end

new text begin

(c) For purposes of this subdivision, a restriction on the number or type of licenses that

a business may hold applies to every cooperative member or every director, manager, and

general partner of a cannabis business.

new text end

new text begin

Subd. 9.

new text end

new text begin

Conversion of licenses.

new text end

new text begin

(a) By January 1, 2027, the office must convert any

existing medical cannabis combination business licenses to cannabis macrobusiness licenses.

new text end

new text begin

(b) Beginning January 1, 2028, the office may determine the number of available cannabis

macrobusiness licenses for applicants who do not have an existing license under this chapter.

The office must make the determination under this paragraph according to the requirements

of section 342.14, subdivision 1a. If the office is accepting applications for cannabis

macrobusiness licenses from applicants without an existing license under this chapter, the

office must announce the number of cannabis macrobusiness licenses available and the date

on which applications will be accepted. The number of licenses available to social equity

applicants must be equal to or greater than the number of licenses available to all applicants.

Applicants for cannabis macrobusiness licenses must comply with the application and

licensing requirements of this chapter.

new text end

Sec. 27.

Minnesota Statutes 2025 Supplement, section 342.61, subdivision 4, is amended

to read:

Subd. 4.

Testing of samples; disclosures.

(a) On a schedule determined by the office,

every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis

manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency

hemp edible manufacturer, or
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
shall

make each batch of cannabis flower, cannabis products, artificially derived cannabinoids,

lower-potency hemp edibles, or hemp-derived consumer products grown, manufactured, or

imported by the cannabis business or hemp business available to a cannabis testing facility.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis

manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency

hemp edible manufacturer, or
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
must

disclose all known information regarding pesticides, fertilizers, solvents, or other foreign

materials, including but not limited to catalysts used in creating artificially derived

cannabinoids, applied or added to the batch of cannabis flower, cannabis products, artificially

derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products

subject to testing. Disclosure must be made to the cannabis testing facility and must include

information about all applications by any person, whether intentional or accidental.

(c) A
deleted text begin
cannabis business
deleted text end
new text begin
license holder
new text end
shall select one or more representative samples

from each batch, test the samples for the presence of contaminants, and test the samples for

potency and homogeneity and to allow the cannabis flower, cannabis product, artificially

derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be

accurately labeled with its cannabinoid profile. Testing for contaminants must include testing

for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide

residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include

testing for other contaminants. A cannabis testing facility must destroy or return to the
deleted text begin

cannabis business or hemp business
deleted text end
new text begin
license holder
new text end
any part of the sample that remains after

testing.

Sec. 28.

Minnesota Statutes 2024, section 342.61, subdivision 5, is amended to read:

Subd. 5.

Test results.

(a) If a sample meets the applicable testing standards, a cannabis

testing facility shall issue a certification to a cannabis microbusiness, cannabis

mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an

endorsement to import products, lower-potency hemp edible manufacturer, or
deleted text begin
medical
deleted text end

cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
and the cannabis business or hemp business

may then sell or transfer the batch of cannabis flower, cannabis products, artificially derived

cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products from which

the sample was taken to another cannabis business or hemp business, or offer the cannabis

flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products

for sale to customers or patients. If a sample does not meet the applicable testing standards

or if the testing facility is unable to test for a substance identified pursuant to subdivision

4, paragraph (b), the batch from which the sample was taken shall be subject to procedures

established by the office for such batches, including destruction, remediation, or retesting.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis

manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency

hemp edible manufacturer, or
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
must

maintain the test results for cannabis flower, cannabis products, artificially derived

cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products grown,

manufactured, or imported by that cannabis business or hemp business for at least five years

after the date of testing.

(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis

manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency

hemp edible manufacturer, or
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
shall

make test results maintained by that cannabis business or hemp business available for review

by any member of the public, upon request. Test results made available to the public must

be in plain language.

Sec. 29.

Minnesota Statutes 2025 Supplement, section 342.63, subdivision 2, is amended

to read:

Subd. 2.

Content of label; cannabis.

All cannabis flower and hemp-derived consumer

products that consist of hemp plant parts sold to customers or patients must have affixed

on the packaging or container of the cannabis flower or hemp-derived consumer product a

label that contains at least the following information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,

cannabis cultivator,
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
, or industrial

hemp grower where the cannabis flower or hemp plant part was cultivated;

(2) the net weight of cannabis flower or hemp plant parts in the package or container;

(3) the batch number;

(4) the cannabinoid profile;

(5) a universal symbol established by the office indicating that the package or container

contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a

hemp-derived consumer product;

(6) verification that the cannabis flower or hemp plant part was tested according to

section
342.61
and that the cannabis flower or hemp plant part complies with the applicable

standards;

(7) information on the usage of the cannabis flower or hemp-derived consumer product;

(8) the following statement: "Keep this product out of reach of children."; and

(9) any other statements or information required by the office.

Sec. 30.

Minnesota Statutes 2025 Supplement, section 342.63, subdivision 3, is amended

to read:

Subd. 3.

Content of label; cannabinoid products.

(a) All cannabis products,

lower-potency hemp edibles, hemp concentrate, hemp-derived consumer products other

than products subject to the requirements under subdivision 2, medical cannabinoid products,

and hemp-derived topical products sold to customers or patients must have affixed to the

packaging or container of the cannabis product a label that contains at least the following

information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,

cannabis cultivator,
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
, or industrial

hemp grower that cultivated the cannabis flower or hemp plant parts used in the cannabis

product, lower-potency hemp edible, hemp-derived consumer product, or medical

cannabinoid product;

(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,

cannabis manufacturer, lower-potency hemp edible manufacturer,
deleted text begin
medical
deleted text end
cannabis
deleted text begin

combination business
deleted text end
new text begin
macrobusiness
new text end
, or industrial hemp grower that manufactured the

cannabis concentrate, hemp concentrate, or artificially derived cannabinoid and, if different,

the name and license number of the cannabis microbusiness, cannabis mezzobusiness,

cannabis manufacturer, lower-potency hemp edible manufacturer, or
deleted text begin
medical
deleted text end
cannabis
deleted text begin

combination business
deleted text end
new text begin
macrobusiness
new text end
that manufactured the product;

(3) the net weight of the cannabis product, lower-potency hemp edible, or hemp-derived

consumer product in the package or container;

(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer

product;

(5) the batch number;

(6) the serving size;

(7) the cannabinoid profile per serving and in total;

(8) a list of ingredients;

(9) a universal symbol established by the office indicating that the package or container

contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a

hemp-derived consumer product;

(10) a warning symbol developed by the office in consultation with the commissioner

of health and the Minnesota Poison Control System that:

(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;

(ii) is in a highly visible color;

(iii) includes a visual element that is commonly understood to mean a person should

stop;

(iv) indicates that the product is not for children; and

(v) includes the phone number of the Minnesota Poison Control System;

(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived

consumer product, or medical cannabinoid product was tested according to section
342.61

and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product,

or medical cannabinoid product complies with the applicable standards;

(12) information on the usage of the product;

(13) the following statement: "Keep this product out of reach of children."; and

(14) any other statements or information required by the office.

(b) The office may by rule establish alternative labeling requirements for lower-potency

hemp edibles that are imported into the state if those requirements provide consumers with

information that is substantially similar to the information described in paragraph (a).

Sec. 31.

Minnesota Statutes 2024, section 342.63, subdivision 4, is amended to read:

Subd. 4.

Additional content of label; medical cannabis flower and medical

cannabinoid products.

In addition to the applicable requirements for labeling under

subdivision 2 or 3, all medical cannabis flower and medical cannabinoid products must

include at least the following information on the label affixed to the packaging or container

of the medical cannabis flower or medical cannabinoid product:

(1) the patient's name and date of birth;

(2)
new text begin
if applicable,
new text end
the name and date of birth of the patient's registered designated caregiver

or, if listed on the registry verification, the name of the patient's parent, legal guardian, or

spouse
deleted text begin
, if applicable
deleted text end
; and

(3) the patient's registry identification number.

Sec. 32.

Minnesota Statutes 2025 Supplement, section 342.63, subdivision 6, is amended

to read:

Subd. 6.

Additional information.

(a) A cannabis microbusiness, cannabis mezzobusiness,

cannabis retailer, or
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
must provide

customers and patients with the following information:

(1) factual information about impairment effects and the expected timing of impairment

effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products,

lower-potency hemp edibles, and hemp-derived consumer products;

(2) a statement that customers and patients must not operate a motor vehicle or heavy

machinery while under the influence of cannabis flower, cannabis products, lower-potency

hemp edibles, and hemp-derived consumer products;

(3) resources customers and patients may consult to answer questions about cannabis

flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer

products, and any side effects and adverse effects;

(4) contact information for the poison control center and a safety hotline or website for

customers to report and obtain advice about side effects and adverse effects of cannabis

flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer

products;

(5) substance use disorder treatment options; and

(6) any other information specified by the office.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or
deleted text begin
medical
deleted text end

cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
may include the information described in

paragraph (a) by:

(1) including the information on the label affixed to the packaging or container of cannabis

flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer

products;

(2) posting the information in the premises of the cannabis microbusiness, cannabis

mezzobusiness, cannabis retailer, or
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
;

or

(3) providing the information on a separate document or pamphlet provided to customers

or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency

hemp edible, or a hemp-derived consumer product.

Sec. 33.

Minnesota Statutes 2024, section 342.80, is amended to read:

342.80 LAWFUL ACTIVITIES.

(a) Notwithstanding any law to the contrary, the cultivation, manufacturing, possessing,

and selling of cannabis flower, cannabis products, artificially derived cannabinoids,

lower-potency hemp edibles, and hemp-derived consumer products by a licensed cannabis

business or hemp business in conformity with the rights granted by a cannabis business

license or hemp business license is lawful and may not be the grounds for the seizure or

forfeiture of property, arrest or prosecution, or search or inspections except as provided by

this chapter.

(b) A person acting as an agent of a cannabis microbusiness, cannabis mezzobusiness,

cannabis retailer,
deleted text begin
medical
deleted text end
cannabis
deleted text begin
combination business
deleted text end
new text begin
macrobusiness
new text end
, or lower-potency

hemp edible retailer who sells or otherwise transfers cannabis flower, cannabis products,

lower-potency hemp edibles, or hemp-derived consumer products to a person under 21 years

of age is not subject to arrest, prosecution, or forfeiture of property if the person complied

with section
342.27, subdivision 4
, and any rules promulgated pursuant to this chapter.

Sec. 34.
new text begin
REVISOR INSTRUCTION.
new text end

new text begin

The revisor of statutes must renumber Minnesota Statutes, section 342.515, as section

342.295 and make any necessary cross-reference changes consistent with this renumbering.

new text end

new text begin

EFFECTIVE DATE.

new text end

new text begin

This section is effective January 1, 2027.

new text end

Sec. 35.
new text begin
REPEALER.
new text end

new text begin

Minnesota Statutes 2024, section 342.51, subdivision 1,

new text end

new text begin

is repealed.

new text end

APPENDIX

Repealed Minnesota Statutes: 26-08065

342.51 MEDICAL CANNABIS ENDORSEMENTS.

Subdivision 1.

Endorsement; authorized actions.

(a) The office may issue a medical cannabis endorsement to a cannabis business authorizing the business to:

(1) cultivate medical cannabis;

(2) process medical cannabinoid products; or

(3) sell or distribute medical cannabis flower and medical cannabinoid products to any person authorized to receive medical cannabis flower or medical cannabinoid products.

(b) The office must issue a medical cannabis cultivation endorsement to a cannabis license holder if the license holder:

(1) is authorized to cultivate cannabis;

(2) submits a medical cannabis endorsement application to the office; and

(3) otherwise meets all applicable requirements established by the office.

(c) A medical cannabis cultivation endorsement entitles the license holder to grow cannabis plants within the approved amount of space from seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package and label cannabis flower as medical cannabis flower, sell medical cannabis flower to cannabis businesses with a medical cannabis endorsement, and perform other actions approved by the office.

(d) The office must issue a medical cannabis processor endorsement to a cannabis license holder if the license holder:

(1) is authorized to manufacture cannabis products;

(2) submits a medical cannabis endorsement application to the office; and

(3) otherwise meets all applicable requirements established by the office.

(e) A medical cannabis processor endorsement entitles the license holder to:

(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, and hemp concentrate from cannabis businesses with a medical cannabis cultivator endorsement or a medical cannabis processor endorsement;

(2) purchase hemp plant parts from industrial hemp growers;

(3) make cannabis concentrate from medical cannabis flower;

(4) make hemp concentrate, including hemp concentrate with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(5) manufacture medical cannabinoid products;

(6) package and label medical cannabinoid products for sale to cannabis businesses with a medical cannabis processer endorsement or a medical cannabis retailer endorsement; and

(7) perform other actions approved by the office.

(f) The office must issue a medical cannabis retailer endorsement to a cannabis license holder if the license holder:

(1) submits a medical cannabis retail endorsement application to the office;

(2) has at least one employee who earned a medical cannabis consultant certificate issued by the office and has completed the required training or has at least one employee who is a licensed pharmacist under chapter 151; and

(3) otherwise meets all applicable requirements established by the office.

(g) A medical cannabis retail endorsement entitles the license holder to purchase medical cannabis flower and medical cannabinoid products from cannabis businesses with medical cannabis cultivator endorsements and medical cannabis processor endorsements, and sell or distribute medical cannabis flower, medical cannabinoid products, and associated paraphernalia to any person authorized to receive medical cannabis flower or medical cannabinoid products.

(h) A medical cannabis business with a medical cannabis retail endorsement must verify that all medical cannabis flower and medical cannabinoid products have passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabis flower and medical cannabinoid products before the cannabis business with a medical cannabis retail endorsement may distribute the medical cannabis flower or medical cannabinoid product to any person enrolled in the registry program.